InvestorsHub Logo
Followers 8
Posts 1379
Boards Moderated 0
Alias Born 03/27/2013

Re: Biobillionair post# 107305

Sunday, 06/04/2017 11:24:56 AM

Sunday, June 04, 2017 11:24:56 AM

Post# of 426330
I think much of the impact of this patent will be a product of how quickly the FDA grants NCE status to AMR102. If they play the same delaying game they did with Vascepa, I don't think we see much benefit in the short term. That said, I agree this is a massive patent grant and hope the FDA has gained some respect for "our little Amarin".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News